Taiwan Biomaterial , Ltd. (6649.TWO) has a profit margin of 18.19%, above the sector sector average of 13.2%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Taiwan Biomaterial , Ltd.'s profit margin stands at 18.19% as of June 2026. That compares with 17.14% in the prior-year period — up 6.1% year over year. That is above the sector sector average of 13.2%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Taiwan Biomaterial , Ltd. reported 18.19% in profit margin versus 17.14% a year earlier — a 6.1% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
Taiwan Biomaterial , Ltd. sits higher the its sector benchmark (13.2%) with a profit margin of 18.19%. That is roughly 37.8% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A profit margin of 18.19% for Taiwan Biomaterial , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Taiwan Biomaterial , Ltd.'s profit margin evolved across reporting periods, while the comparison chart places 6649.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.